Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.
Also called NCT03212365
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 295 participants
- Registry
-
NCT03212365
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03212365. Randomized; double masking; primary purpose other. Start 2017-07-03 (actual); primary completion 2019-06-02 (actual). Results posted on 2020-09-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
- Condition
- Venous Thromboembolism
- Condition
- Deep Venous Thrombosis
- Condition
- Pulmonary Embolus
- Condition
- Reconstructive Surgery
- Intervention (Drug)
- Fixed dose
- Intervention (Drug)
- Variable dose
- Lead sponsor
- University of Utah
- Collaborator
- Stanford University
Record details
- Record id
cardio:ct-nct03212365- Content hash
0534dc8f167fa35636b08a4de39d8d510aea45176a9649964f39edefb5e1e6e4